Dr. Ortuzar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Lilly Corporate Center
Indianapolis, IN 46225Phone+1 317-433-0280Fax+1 317-277-3238- Is this information wrong?
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1992 - 1993
University of Miami/Jackson Health SystemResidency, Internal Medicine, 1989 - 1992
Pontifical Catholic University Mother and TeacherClass of 1988
Certifications & Licensure
IN State Medical License 2008 - 2025
MA State Medical License 2022 - 2024
MD State Medical License 1995 - 2001
OH State Medical License 1992 - 1994
Clinical Trials
- Phase 1a Study to Evaluate Immunogenicity of ASV® Start of enrollment: 2019 May 16
- Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer Start of enrollment: 2019 Apr 01
- RaPiDS- A Phase 2 Study of Anti-PD-1 Independently or in Combination With Anti-CTLA-4 in Second-Line Cervical Cancer Start of enrollment: 2019 Jun 01
Publications & Presentations
PubMed
- A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.Hammond, T., Purbhoo, M., Kadel, S., Ritz, J., Nikiforow, S., Daley, H., Shaw, K., van Besien, K., Gomez-Arteaga, A., Stevens, D., Ortuzar, W., Michelet, X., Smith, R....> ;Nature Communications. 2024 Feb 6
- 114 citationsPRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizu...Ralph Zinner, Coleman K. Obasaju, David R. Spigel, Robert W. Weaver, J. Thaddeus Beck, David M. Waterhouse, Manuel R. Modiano, Borys Hrinczenko, Petros G. Nikolinakos,...> ;Journal of Thoracic Oncology. 2015 Jan 1
- 26 citationsBrain metastases as the primary site of relapse in two randomized phase III pemetrexed trials in advanced non-small-cell lung cancer.Waldo I. Ortuzar, Nasser H. Hanna, Eduardo J. Pennella, Guangbin Peng, Corey J. Langer, Matthew J. Monberg, Giorgio V. Scagliotti> ;Clinical Lung Cancer. 2012 Jan 1
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
